Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,588.0
24.8 (0.97%)

 

  • STI Straits Times Index
    2,588.0
    24.8 (0.97%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,566.5
    9.9 (0.64%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,204.4
    -39.7 (-0.16%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,320.3
    1.0 (0.03%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,264.5
    420.5 (1.84%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,241.5
    8.0 (0.15%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 450.3M
  • Value: 396.8M
  • Rise: 173
  • Fall: 60
  • Unch: 575

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.023+0.005
Medtecs Intl1.510+0.100
QT Vascular0.008+0.001
Sembcorp Marine0.245-0.105
UMS1.180+0.100
Rex Intl0.184+0.002
ThaiBev0.610+0.010
Genting Sing0.730+0.025
IPS Securex0.117+0.005
YZJ Shipbldg SGD0.955+0.005

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,265.5 -284.5
HSCEI 9,743.2 -110.0
Jakarta 4,863.1 -41.0
Nikkei 225 22,047.8 -464.2
SSE Comp 2,960.5 -10.1
Shanghai A 3,103.1 -10.6
Shanghai B 211.8 -1.7
KOSPI 2,097.3 -37.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ASCENTAGE-B ASCENTAGE-B
Quotes 15 Minutes Delayed. Updated at 13 Aug 2020 10:29
Last (HKD): 34.700 Change: +0.550 High: 34.900 Remarks: -
Change (%): +1.61 Low: 34.150
Open 34.150 Yesterday's Close 34.150
Buy Price 34.650 Sell Price 34.800
Buy Volume ('000) 0.4 Sell Volume ('000) 0.3
Cumulative Volume ('000) 33.6 Cumulative Value 1,162,515
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a -7.49884 Trailing EPS (HKD) e -7.49884 NAV (HKD) b 4.4487
PE a - Trailing PE f - Price / NAV b 7.8000
Dividend (HKD) d - Cash In Hand (HKD) g 4.4087 Issued & Paid-up Shares c 223,902,000
Dividend Yield (%) d - Price / Cash In Hand g 7.871 Treasury Shares h 12,229,000
Beta - 75 Daysi 0.864 R-Squared - 75 Days(%)i 7.10 Market Cap (M) 7,769.399
Beta - 500 Daysi 0.999 R-Squared - 500 Days (%)i 14.73 Enterprise Value (M) 6,895.718
Piotroski F Score 3 Exchange Code 6855 Par Value ( USD ) 0.00010
52 Weeks Volatility (%) n.a. 6-Month VWAP 37.358 Free Float (%) 46.0
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 16 Jul 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 12 Aug 2020.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ASCENTAGE-B HKEx 7,769.399 - - 7.8000 -
Industry Biotechnology HKEx 56,925.346 22.296 26.013 6.5752 2.247
Local Peer AMGEN-T HKEx 585,694.000 9.532 10.295 7.0897 4.589
Local Peer WUXI BIO HKEx 221,879.573 193.011 193.011 15.5155 -
Local Peer SINO BIOPHARM HKEx 174,382.824 56.816 57.336 5.0332 0.575
Local Peer BEIGENE HKEx 150,266.520 - - 7.6443 -
Local Peer GENSCRIPT BIO HKEx 29,670.397 - - 9.9472 -
Local Peer 3SBIO HKEx 23,222.611 21.033 21.033 2.1569 -
Local Peer HAOHAI BIOTEC HKEx 18,864.327 44.869 44.869 3.2073 0.722
Local Peer VIVA BIOTECH HKEx 17,900.379 59.376 59.376 9.0034 0.174
Local Peer ALPHAMAB-B HKEx 14,954.109 - - 5.5108 -
Local Peer FRONTAGE HKEx 7,604.467 52.654 52.656 3.6884 -
Local Peer KINTOR PHARMA-B HKEx 5,725.545 - - 15.4892 -
Local Peer SINOMAB BIO-B HKEx 3,421.216 - - 2.7021 -
Other Local Peers LEE'S PHARM (HKEx), ASCLETIS-B (HKEx), ESSEX BIO-TECH (HKEx), UNI-BIO GROUP (HKEx), CT ENTERPRISE (HKEx), BIOSINO BIO-TEC (HKEx), REGENT PACIFIC (HKEx), HAO WEN H-NEW (HKEx), HAO WEN H-OLD (HKEx)
Global Peer AMGEN INC NASDAQ 141,573.954 18.053 19.396 13.2821 2.423
Global Peer CSL ASX 127,919.225 47.679 44.159 14.7911 0.941
Global Peer GILEAD SCIENCES INC NASDAQ 86,306.085 16.024 - 4.7876 3.697
Global Peer VERTEX PHARMACEUTICAL NASDAQ 70,547.487 59.948 33.904 9.3823 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 65,149.123 30.792 21.836 7.1929 -
Global Peer ILLUMINA INC NASDAQ 50,244.440 50.144 72.503 11.0113 -
Global Peer BIOGEN INC NASDAQ 46,420.538 7.883 7.832 4.1049 -
Global Peer MODERNA INC NASDAQ 27,431.688 - - 9.3087 -
Global Peer SEATTLE GENETICS INC NASDAQ 27,628.984 - - 15.2303 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,526.601 9.369 26.624 2.1473 -
Other Global Peers BIOMARIN PHARMACEUTICAL (NASDAQ), INCYTE CORPORATION (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NOVAVAX INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), ACADIA PHARMACEUTICALS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), Lonza (SGX), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), FIBROGEN INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), INSMED INC (NASDAQ), ALKERMES PLC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), ALLOVIR INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), TG THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), VIELA BIO INC (NASDAQ), VAXCYTE INC (NASDAQ), VERACYTE INC (NASDAQ), XENCOR INC (NASDAQ), UNIQURE N.V. (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), ARCUS BIOSCIENCES INC (NYSE), DICERNA PHARMACEUTICALS INC. (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), MESOBLAST LTD (ASX), ZENTALIS PHARMACEUTICALS INC (NASDAQ), COMPUGEN (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CORTEXYME INC (NASDAQ), EPIZYME INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), REGENXBIO INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), ARVINAS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), POLYNOVO LIMITED (ASX), NANTKWEST INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), MORPHIC HOLDING INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), PRECIGEN INC (NASDAQ), NKARTA INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), PASSAGE BIO INC (NASDAQ), KADMON HLDGS INC (NYSE), BIOCRYST PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), PERSONALIS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), IMMATICS N V (NASDAQ), AKOUOS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), AGENUS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), AVROBIO INC (N